Related Experiment Video
Updated: Mar 16, 2026
08:08
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
14.7K
Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases
Oksana A Shlobin1, A Whitney Brown1, Steven D Nathan1
1Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA.
Chest
|August 25, 2016
Summary
Pulmonary hypertension (PH) linked to diffuse lung diseases (DPLD) is common, but its causes and impact are unclear. Research is ongoing to understand and treat this condition, which worsens patient outlook.
Area of Science:
- Pulmonology
- Cardiology
- Internal Medicine
Background:
- Pulmonary hypertension (PH) is characterized by elevated pulmonary vascular resistance.
- Most PH cases are secondary to underlying conditions, not idiopathic pulmonary arterial hypertension (PAH).
- The World Health Organization (WHO) classification categorizes PH by etiology, with Group 3 encompassing PH associated with lung disease.
Purpose of the Study:
- To review PH specifically in the context of diffuse parenchymal lung diseases (DPLDs).
- To explore the pathophysiologic mechanisms and clinical significance of PH in DPLDs.
- To discuss the investigational treatment landscape for PH related to DPLDs.
Main Methods:
- Literature review focusing on PH in DPLDs.
- Analysis of existing data on associations between PH and DPLDs.
- Discussion of current understanding and future research directions.
Main Results:
- PH is frequently associated with DPLDs, including idiopathic interstitial pneumonias.
- The precise mechanisms driving PH in DPLDs and its full clinical impact require further elucidation.
- Treatment strategies for PH in DPLDs are currently investigational.
Conclusions:
- PH in DPLD is a significant clinical concern with negative prognostic implications.
- Understanding the pathophysiology is crucial for developing effective treatments.
- The expanding availability of pulmonary vasoactive agents offers potential therapeutic avenues.
More Related Videos
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
766
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
766
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
717
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
717
01:17Other Pulmonary Disorders
1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
01:24Chronic Obstructive Pulmonary Disease
2.9K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.9K
01:29Pulmonary Embolism I: Introduction
1.1K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.1K